---
figid: PMC7068598__fphar-11-00198-g002
figtitle: Emerging signaling pathways in CSCs
organisms:
- Nicotiana tabacum
- Flakea papillata
- Homo sapiens
- Mus musculus
- Adenoviridae
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7068598
filename: fphar-11-00198-g002.jpg
figlink: pmc/articles/PMC7068598/figure/F2/
number: F2
caption: Emerging signaling pathways in CSCs. Silencing of both YAP1 and IGF2BP3 restores
  TGF-β signaling and eliminates drug resistance of CSCs. HBV X protein (HBx) promotes
  the initiation of CSC by promoting the expression of α-fetoprotein through the PI3K/AKT
  signaling pathway. Shp2 promotes CSC expansion and prognosis by activating β-catenin
  signaling. β-catenin interacts with TCF/LEF factors and induces transcriptional
  activity of Wnt signaling genes such as cyclin D1, c-Myc, and surviving. Chitosan
  promotes stem cell properties associated with Wnt-STAT3 signaling. miR-491 reduces
  the CSC-like properties of HCC via the NF-κB signaling pathway. Inhibition of miR-21
  attenuates osteopontin (OPN) expression by blocking Notch and its downstream target
  transcription factor RUNX2/HES1. OPN also promotes CSC-like phenotypes via the integrin
  αvβ3–NF-κB–HIF-1α pathway.
papertitle: 'Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy.'
reftext: Yafei Wu, et al. Front Pharmacol. 2020;11:198.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.795207
figid_alias: PMC7068598__F2
figtype: Figure
redirect_from: /figures/PMC7068598__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7068598__fphar-11-00198-g002.html
  '@type': Dataset
  description: Emerging signaling pathways in CSCs. Silencing of both YAP1 and IGF2BP3
    restores TGF-β signaling and eliminates drug resistance of CSCs. HBV X protein
    (HBx) promotes the initiation of CSC by promoting the expression of α-fetoprotein
    through the PI3K/AKT signaling pathway. Shp2 promotes CSC expansion and prognosis
    by activating β-catenin signaling. β-catenin interacts with TCF/LEF factors and
    induces transcriptional activity of Wnt signaling genes such as cyclin D1, c-Myc,
    and surviving. Chitosan promotes stem cell properties associated with Wnt-STAT3
    signaling. miR-491 reduces the CSC-like properties of HCC via the NF-κB signaling
    pathway. Inhibition of miR-21 attenuates osteopontin (OPN) expression by blocking
    Notch and its downstream target transcription factor RUNX2/HES1. OPN also promotes
    CSC-like phenotypes via the integrin αvβ3–NF-κB–HIF-1α pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Igf2bp3
  - Tgfb1
  - Ltbp1
  - Egfr
  - Pik3r1
  - Yap1
  - Spp1
  - Myc
  - Nol3
  - Pou5f1
  - Akt1
  - Mtor
  - Gsk3b
  - Ctnnb1
  - ras
  - Hras
  - Kras
  - Rem1
  - Stat3
  - Ptk2
  - Ptpn11
  - Mapk8
  - Il33
  - Zhx2
  - Nanog
  - Cdkn1b
  - Dctn6
  - Psmd9
  - Trp53
  - Nfkb1
  - Dnmt1
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Ephb2
  - Mapk1
  - Mir491
  - Hif1a
  - Mdk
  - Snai1
  - Smo
  - Smox
  - Unk
  - Sirt1
  - Itk
  - Slc22a3
  - IGF2BP3
  - TGFB1
  - TGFB2
  - TGFB3
  - EGFR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - YAP1
  - SPP1
  - MYC
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - POU5F1
  - POU5F1P3
  - POU5F1P4
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - GSK3A
  - GSK3B
  - CTNNB1
  - KRAS
  - HRAS
  - NRAS
  - STAT3
  - PTK2
  - PTPN11
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - MAPK8
  - MAPK9
  - MAPK10
  - IL33
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - NANOG
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - TP53
  - TP63
  - TP73
  - NFKB1
  - DNMT1
  - DNMT3A
  - DNMT3B
  - DNMT3L
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - EPHB2
  - MAPK3
  - MIR491
  - HIF1A
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - SNAI1
  - SMO
  - SMOX
  - UNK
  - SIRT1
  - ITK
  - SLC22A3
  - dpp
  - gbb
  - put
  - mav
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - .na.character
  - yki
  - Akt
  - Tor
  - sgg
  - arm
  - Ras64B
  - Ras85D
  - Fak
  - Ts
  - csw
  - Mad
  - bsk
  - Raf
  - DCTN6-p27
  - dap
  - CG9588
  - p53
  - betaTub60D
  - hth
  - Dif
  - dl
  - Rel
  - Mt2
  - Nmt
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - Erk7
  - rl
  - sima
  - Dsor1
  - Mtk
  - sna
  - smo
  - sm
  - unk
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Alcohol
  - tumor
---
